Long emission wavelength chemiluminescent compounds and their use in test assays
Patent 5395752 Issued on March 7, 1995. Estimated Expiration Date: 
March 19, 2013. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
March 19, 2013. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesProcess for amplifying nucleic acid sequences Polysubstituted aryl acridinium esters Patent #: 5110932 InventorsAssigneeApplicationNo. 035130 filed on 03/19/1993US Classes:435/6, Involving nucleic acid435/7.1, Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay435/91.2, Acellular exponential or geometric amplification (e.g., PCR, etc.)435/968, HIGH ENERGY SUBSTRATES (E.G., FLUORESCENT, CHEMILUMINESCENT, RADIOACTIVE, ETC.)436/172, With fluorescence or luminescence436/501, BIOSPECIFIC LIGAND BINDING ASSAY436/518, INVOLVING AN INSOLUBLE CARRIER FOR IMMOBILIZING IMMUNOCHEMICALS436/536, INVOLVING IMMUNE COMPLEX FORMED IN LIQUID PHASE436/805, OPTICAL PROPERTY546/102Acridines (including hydrogenated)ExaminersPrimary: Parr, MargaretAssistant: Horlick, Kenneth R. Attorney, Agent or FirmForeign Patent References
International ClassesC12Q 001/68G01N 033/48 C12P 019/34 AbstractAn assay method incorporating at least two different chemiluminescent compounds for detection and/or quantitation of at least two substances in a test sample is described. The synthesis of chemiluminescent reagents or conjugates for use in such methods as well as kits incorporating such reagents are also disclosed. The assays have particular application in the field of clinical diagnostics.Field of SearchInvolving nucleic acidInvolving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay Acellular exponential or geometric amplification (e.g., PCR, etc.) HIGH ENERGY SUBSTRATES (E.G., FLUORESCENT, CHEMILUMINESCENT, RADIOACTIVE, ETC.) Acridines (including hydrogenated) With fluorescence or luminescence BIOSPECIFIC LIGAND BINDING ASSAY INVOLVING AN INSOLUBLE CARRIER FOR IMMOBILIZING IMMUNOCHEMICALS INVOLVING IMMUNE COMPLEX FORMED IN LIQUID PHASE OPTICAL PROPERTY |
| ||||||||||||||
